>
Earlier this week, we tweeted some articles published online at Scientific American that provide some perspectives on the complexity and high costs of drug discovery – so far, two have been published, here and here. The tweet elicited a thought-provoking response from one of our researchers, Christopher McCabe:
This is one of many possible ways to view (either in support or in criticism of) the drug discovery process, a topic that merits a great deal of discussion, and not merely because of the massive investments made by Big Pharma. In the spirit of our Right Turn series (see description at bottom), here’s another perspective, one that posits an open source strategy:
We invite you to share your views on this complicated topic in the comments section.
—
Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.
As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.
Lisa Willemse
Latest posts by Lisa Willemse (see all)
- Toronto team tackling unmet need in cell manufacturing using synthetic biology - January 9, 2020
- Medicine by Design-funded researchers devise new strategy to improve the safety of cell therapies - February 22, 2019
- Right Turn: These three videos show why we should be impressed by our young stem cell researchers - November 18, 2016
Trackbacks/Pingbacks